SCHEMBL19960753

SCHEMBL19960753

CC(C)(C)OC(=O)NCc1cc(Oc2cccc(C(=O)NCCNC(=O)CCCCCNC(=O)CCCCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)c2)nc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GIGYF2 Q6Y7W6 1/20 0.46
▸ SORT1 Q99523 1/20 0.45
▸ PSEN1 P49768 2/20 0.45
▸ PSEN2 P49810 2/20 0.45
▸ APH1B Q8WW43 2/20 0.45
▸ NCSTN Q92542 2/20 0.45
▸ APH1A Q96BI3 2/20 0.45
▸ PSENEN Q9NZ42 2/20 0.45
▸ ITGB1 P05556 1/20 0.44
▸ ITGA4 P13612 1/20 0.44
▸ GBA1 P04062 1/20 0.43
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ LY6K Q17RY6 1/20 0.42
▸ LOX P28300 4/20 0.41
▸ LOXL2 Q9Y4K0 4/20 0.41
▸ PSMD11 O00231 1/20 0.41
▸ EGFR P00533 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067002 0.99 SORT1 (0.46) GIGYF2SORT1PSEN1PSEN2APH1B
SCHEMBL19952637 0.92 GIGYF2 (0.46) GIGYF2SORT1PSEN1PSEN2APH1B
SCHEMBL19952732 0.92 ITGB1 (0.47) GIGYF2SORT1PSEN1PSEN2APH1B
SCHEMBL19952710 0.90 LOXL2 (0.53) GIGYF2ITGB1ITGA4CA12CA1
Hydrochloric Acid SCHEMBL19952640 0.89 LOXL2 (0.53) GIGYF2ITGB1ITGA4CA12CA1
SCHEMBL19952750 0.89 LOXL2 (0.54) GIGYF2ITGB1ITGA4CA12CA1
Hydrochloric Acid SCHEMBL19952655 0.89 LOXL2 (0.54) GIGYF2ITGB1ITGA4CA12CA1
SCHEMBL21066980 0.88 SORT1 (0.46) GIGYF2SORT1PSEN1PSEN2APH1B
SCHEMBL21067001 0.87 SORT1 (0.47) GIGYF2SORT1PSEN1PSEN2APH1B
SCHEMBL19952704 0.84 LOXL2 (0.52) SORT1LY6KLOXLOXL2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190192697-A1 CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF PHARMAKEA, INC. 2019-06-27 — — US disclosed
US-20190192697-A1 CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF PHARMAKEA, INC. 2019-06-27 — — US disclosed
WO-2018048928-A1 CHEMICAL PROBES OF LYSYL OXIDASE-LIKE 2 AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190192697-A1 CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF LOXL2, LOXL1, LOXL3 GIGYF2 2254/4885SORT1 1850/4885PSEN1 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback